Generex Biotechnology, a developer of drug delivery systems and technologies, has received a new patent in Morocco.
Subscribe to our email newsletter
The Moroccan Industrial and Commercial Property Office granted the company its first Moroccan patent, which contains claims to pharmaceutical formulations effective to deliver a pharmaceutical agent across oral membranes as well as device and method claims.
Rose Perri, COO of Generex, said: “While our regulatory scope in the Middle East region expands, the granting of this application in Morocco is a timely one. We look forward to other patent grants that will augment the value of our increasing intellectual property portfolio.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.